About Clindataceutics Private Limited
Data last updated:
Clindataceutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 22 February 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33100TG2018PTC122446.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Naresh Namani and Suresh Azmeera.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Plot No:28 H.No:1 – 30 – 588/1 Sivalayam Sivanagar Khanajiguda Alwal, Hyderabad, Telangana, India – 500010.
As per the financials filed for FY 2022, the company reported a revenue of ₹19.81 Lakh. For the same year it recorded a net loss of ₹7.06 Lakh (net margin -35.6%) and EBITDA of -₹9.74 Lakh (EBITDA margin -49.2%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
The company has about 6 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Clindataceutics.
For more details, the company can be reached via its website clindataceutics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No:28 H.No:1 – 30 – 588/1 Sivalayam Sivanagar Khanajiguda Alwal, Hyderabad, Telangana, India – 500010
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Clindataceutics Private Limited
The main business activity of Clindataceutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Clindataceutics Private Limited FY 2022 filings available
Clindataceutics Private Limited reported revenue of ₹19.81 Lakh for FY 2022.
Compounded Annual Growth Rate (CAGR) of Clindataceutics Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over three years. EBITDA fell 223% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Clindataceutics Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹19.81 Lakh | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹9.74 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹7.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Clindataceutics Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -49.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -35.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Clindataceutics are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Clindataceutics Private Limited
Clindataceutics Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lavybens Pharmaceuticals Private Limited | ₹21.83 Lakh (FY 2023) | •••• | •••• | -59.0% | •••• | Hyderabad, Telangana, India |
| Yes Strategy Private Limited | ₹21.11 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Pune, Maharashtra, India |
| Rite-Aid Labs Private Limited | ₹20.68 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Hyderabad, Telangana, India |
| Triyat Scientific Private Limited | ₹20.5 Lakh (FY 2024) | •••• | •••• | 40.0% | •••• | Nagpur, Maharashtra, India |
| Taarmal Bio Care International Private Limited | ₹20.32 Lakh (FY 2025) | •••• | •••• | 78.0% | •••• | Pune, Maharashtra, India |
| Clindataceutics Private Limited this company | ₹19.81 Lakh (FY 2022) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Esente Innovations & Research Solutions Private Limited | ₹19.75 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Bangalore, Karnataka, India |
| Yashan Healthcare Private Limited | ₹19.47 Lakh (FY 2022) | •••• | •••• | 2243.0% | •••• | Pune, Maharashtra, India |
| MK and SK Medicare Private Limited | ₹19.33 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Kolkata, West Bengal, India |
| Navchem Laboratories Private Limited | ₹19.29 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Navi Mumbai, Maharashtra, India |
| Nugenics Research Private Limited | ₹18.92 Lakh (FY 2024) | •••• | •••• | 830.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Clindataceutics by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Clindataceutics Private Limited
Clindataceutics Private Limited is audited by CHANDANALA SRINATH & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHANDANALA SRINATH & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Clindataceutics Private Limited
Clindataceutics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Namani | Director | 22 Feb 2018 | 8 Years 7 Months | Current |
| Suresh Azmeera Also directs: Aira Life Sciences LLP, Cdci Pharma Private Limited | Director | 24 Mar 2022 | 4 Years 6 Months | Current |
Ownership and Shareholding of Clindataceutics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Clindataceutics Private Limited
Clindataceutics Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Clindataceutics Private Limited
Clindataceutics operates one associated brand: Clindataceutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers clinical trial management, data analysis, and regulatory consulting services. | clindataceutics.com |
Employees and EPFO Compliance at Clindataceutics Private Limited
Clindataceutics Private Limited has a workforce of 6 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Clindataceutics Private Limited
Clindataceutics Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Suresh Azmeera ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Clindataceutics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Clindataceutics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Clindataceutics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Clindataceutics Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Clindataceutics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clindataceutics Private Limited
Clindataceutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 22 February 2018 (8+ years old) and is registered under CIN U33100TG2018PTC122446.
Clindataceutics reported revenue of ₹19.81 Lakh for FY 2022.
Clindataceutics has 2 current directors:
- Naresh Namani - Director
- Suresh Azmeera - Director
Clindataceutics reported a net loss of ₹7.06 Lakh (net margin -35.6%) and EBITDA of -₹9.74 Lakh (EBITDA margin -49.2%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Clindataceutics is 3% over three years. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Clindataceutics is U33100TG2018PTC122446. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clindataceutics was incorporated on 22 February 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Clindataceutics by revenue are Lavybens Pharmaceuticals Private Limited, Yes Strategy Private Limited, Rite-Aid Labs Private Limited, Triyat Scientific Private Limited, Taarmal Bio Care International Private Limited and 5 more, all in the Pharma industry (Contract Research).
Suresh Azmeera ceased to be Additional Director on 30 Sep 2022. Suresh Azmeera was appointed as Director on 24 Mar 2022. Azmeera Ramesh ceased to be Additional Director on 30 Nov 2021. Clindataceutics has 5 board changes on record in total.
Clindataceutics can be reached through the website clindataceutics.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Clindataceutics is at Plot No:28 H.No:1 – 30 – 5881 Sivalayam Sivanagar Khanajiguda Alwal, Hyderabad, Telangana, India – 500010.